Benchmarks ended in the red zone yesterday, once again dragged down by declines in momentum and bio-tech stocks. The bearish mood weighed on Nasdaq the most as it suffered the largest decline in two and half years. Separately, discouraging Chinese trade data unnerved investors. The day's positive economic data on unemployment benefits failed to restrict the day's loss.
For a look at the issues currently facing the markets, make sure to read today's Ahead of Wall Street article
The Dow Jones Industrial Average (DJI) dropped 1.6% to close Thursday's trading session at 16,170.22. The Standard & Poor (S&P 500) declined 2.1% to finish at 1,833.08. The tech-laden Nasdaq Composite Index plunged 3.1% to 4,054.11. The fear-gauge CBOE Volatility Index (VIX) surged almost 15% to settle at 15.89. Total volume for the day was roughly 7.5 billion shares, higher than this month's average of 6.8 billion. Advancing stocks were outnumbered by declining stocks on the NYSE. For 22% stocks that advanced, 75% declined.
The day's intense selling pressure in momentum and bio-tech stocks dragged the tech-heavy Nasdaq down. The index suffered its steepest one-day percentage decline since November 2011. The S&P also fell below its 50-day moving average and only about 2% members of the S&P 500 ended in the green. The index posted its biggest decline since February 3 this year. The Dow too posted its worst one-day percentage drop in more than two months.
Declines in momentum stocks had a negative impact on the benchmarks. Shares of momentum stocks such as Boston Scientific Corporation BSX, Red Hat, Inc. RHT, Tesla Motors, Inc. TSLA, Pandora Media, Inc. P and E*TRADE Financial Corporation ETFC plunged 4.5%, 3.9%, 5.9%, 10.5% and 4.3%, respectively.
High-growth stocks from the Consumer Discretionary sector such as online retailer Amazon.com Inc. AMZN, online movie rental company Netflix, Inc. NFLX, online travel company TripAdvisor Inc. TRIP and The Priceline Group Inc. PCLN fell 4.4%, 5.2%, 7.1% and 4.6%, respectively. Overall, the Consumer Discret Select Sector SPDR XLY decreased 2.5%.
Bargain-hunting investors sold bio-tech stocks. Shares of bio-tech companies such as Biogen Idec Inc. BIIB, Gilead Sciences Inc. GILD, Vertex Pharmaceuticals Incorporated VRTX, Amgen Inc. AMGN and Celgene Corporation CELG soared 4.4%, 7.3%, 6.1%, 4.9% and 4.9%, respectively. The Health Care Select Sector SPDR XLV led the decline among the S&P 500 sectors. The sector dropped 3.3%. All the 10 sectors of the S&P 500 ended in the red.
Investors also sold technology stocks. Internet and related stocks such as Facebook, Inc. FB, LinkedIn Corporation LNKD, Yahoo! Inc. YHOO and Google Inc. GOOG plummeted 5.2%, 3.5%, 4.2% and 4.1%, respectively. Overall, the Technology Select Sector SPDR XLK fell 2.3%.
Benchmarks traded in the negative zone right from the beginning of the session owing to disappointing Chinese trade data. Concerns over the strength of the Chinese economy rose after the Chinese government reported that March exports fell 6.6% from a year earlier and imports plunged 11.3% in the same period. However, in March there was a trade surplus of $7.71 billion in contrast to a deficit of $23 billion in February.
Shares of retailer Bed Bath & Beyond Inc. BBBY plunged 6.2% after a survey by FactSet showed that the companies first quarter earnings forecast of 92 cents to 96 cents per share fell short of analysts' estimate of $1.02 per share. The first quarter earnings forecast also fell short of Zacks Consensus Estimate of $1.60 per share.
On the economic front, the U.S Department of Labor reported that seasonally adjusted initial claims decreased 32,000 to 300,000 in the week ending April 5. This fall in application for unemployment benefits reached the lowest level since May 12, 2007. The fall was more than the consensus expectations of initial claims decreasing to 318,000.
Meanwhile, according to the Department of the Treasury, in March total budget receipts aggregated $216.0 billion, a deficit of $37 billion. The deficit of $37 billion was less than the consensus estimate of a deficit of $67.6 billion.
For a look at the issues currently facing the markets, make sure to read today's Ahead of Wall Street article
The Dow Jones Industrial Average (DJI) dropped 1.6% to close Thursday's trading session at 16,170.22. The Standard & Poor (S&P 500) declined 2.1% to finish at 1,833.08. The tech-laden Nasdaq Composite Index plunged 3.1% to 4,054.11. The fear-gauge CBOE Volatility Index (VIX) surged almost 15% to settle at 15.89. Total volume for the day was roughly 7.5 billion shares, higher than this month's average of 6.8 billion. Advancing stocks were outnumbered by declining stocks on the NYSE. For 22% stocks that advanced, 75% declined.
The day's intense selling pressure in momentum and bio-tech stocks dragged the tech-heavy Nasdaq down. The index suffered its steepest one-day percentage decline since November 2011. The S&P also fell below its 50-day moving average and only about 2% members of the S&P 500 ended in the green. The index posted its biggest decline since February 3 this year. The Dow too posted its worst one-day percentage drop in more than two months.
Declines in momentum stocks had a negative impact on the benchmarks. Shares of momentum stocks such as Boston Scientific Corporation BSX, Red Hat, Inc. RHT, Tesla Motors, Inc. TSLA, Pandora Media, Inc. P and E*TRADE Financial Corporation ETFC plunged 4.5%, 3.9%, 5.9%, 10.5% and 4.3%, respectively.
High-growth stocks from the Consumer Discretionary sector such as online retailer Amazon.com Inc. AMZN, online movie rental company Netflix, Inc. NFLX, online travel company TripAdvisor Inc. TRIP and The Priceline Group Inc. PCLN fell 4.4%, 5.2%, 7.1% and 4.6%, respectively. Overall, the Consumer Discret Select Sector SPDR XLY decreased 2.5%.
Bargain-hunting investors sold bio-tech stocks. Shares of bio-tech companies such as Biogen Idec Inc. BIIB, Gilead Sciences Inc. GILD, Vertex Pharmaceuticals Incorporated VRTX, Amgen Inc. AMGN and Celgene Corporation CELG soared 4.4%, 7.3%, 6.1%, 4.9% and 4.9%, respectively. The Health Care Select Sector SPDR XLV led the decline among the S&P 500 sectors. The sector dropped 3.3%. All the 10 sectors of the S&P 500 ended in the red.
Investors also sold technology stocks. Internet and related stocks such as Facebook, Inc. FB, LinkedIn Corporation LNKD, Yahoo! Inc. YHOO and Google Inc. GOOG plummeted 5.2%, 3.5%, 4.2% and 4.1%, respectively. Overall, the Technology Select Sector SPDR XLK fell 2.3%.
Benchmarks traded in the negative zone right from the beginning of the session owing to disappointing Chinese trade data. Concerns over the strength of the Chinese economy rose after the Chinese government reported that March exports fell 6.6% from a year earlier and imports plunged 11.3% in the same period. However, in March there was a trade surplus of $7.71 billion in contrast to a deficit of $23 billion in February.
Shares of retailer Bed Bath & Beyond Inc. BBBY plunged 6.2% after a survey by FactSet showed that the companies first quarter earnings forecast of 92 cents to 96 cents per share fell short of analysts' estimate of $1.02 per share. The first quarter earnings forecast also fell short of Zacks Consensus Estimate of $1.60 per share.
On the economic front, the U.S Department of Labor reported that seasonally adjusted initial claims decreased 32,000 to 300,000 in the week ending April 5. This fall in application for unemployment benefits reached the lowest level since May 12, 2007. The fall was more than the consensus expectations of initial claims decreasing to 318,000.
Meanwhile, according to the Department of the Treasury, in March total budget receipts aggregated $216.0 billion, a deficit of $37 billion. The deficit of $37 billion was less than the consensus estimate of a deficit of $67.6 billion.
AMGEN INC AMGN: Free Stock Analysis Report
AMAZON.COM INC AMZN: Free Stock Analysis Report
BIOGEN IDEC INC BIIB: Free Stock Analysis Report
BOSTON SCIENTIF BSX: Free Stock Analysis Report
CELGENE CORP CELG: Free Stock Analysis Report
E TRADE FINL CP ETFC: Free Stock Analysis Report
GILEAD SCIENCES GILD: Free Stock Analysis Report
NETFLIX INC NFLX: Free Stock Analysis Report
PANDORA MEDIA P: Free Stock Analysis Report
PRICELINE.COM PCLN: Free Stock Analysis Report
RED HAT INC RHT: Free Stock Analysis Report
TRIPADVISOR INC TRIP: Free Stock Analysis Report
TESLA MOTORS TSLA: Free Stock Analysis Report
VERTEX PHARM VRTX: Free Stock Analysis Report
To read this article on Zacks.com click here.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
